Moreover, in vivo for its efficacy in an ALS mouse model, pharmacokinetic profile and brain penetration were investigated as well, compound 107 (1.0, 10, and 20 mg/kg) dose-dependently extended the survival of SOD1 G93A mice at the dose of 300 mg/kg.